Uncategorised - European Medical Journal

Psychedelic pattern

AbbVie expands pipeline with psychedelic therapy

AbbVie has announced the acquisition of Gilgamesh Pharmaceuticals’ lead investigational drug – a next-generation psychedelic compound for moderate-to-severe major depressive disorder.

Night or Day? How Mirabegron Timing Impacts Overactive Bladder Symptoms

Study finds timing of mirabegron dosing affects symptom relief and emotional outcomes in women with overactive bladder.

New Evidence Highlights Genetic Risk in Alopecia Areata

Understand familial and autoimmune risk patterns in alopecia areata, supporting genetic counselling and family screening.

Flu and COVID-19 May Awaken Dormant Breast Cancer Cells

Respiratory viruses such as influenza and SARS-CoV-2 can awaken dormant breast cancer cells, driving metastasis and raising mortality risk in cancer survivors, new research finds.

Toby Maher

Unpacking Rare Lung Diseases: Interstitial Lung Disease

In the third episode of our Rare Lung Diseases podcast series,, host Saranya Ravindran is joined by Toby Maher to explore the often-overlooked world of interstitial lung diseases.

Deep Phenotyping Electronic Records for Personalised Care in Obesity

Learn how deep phenotyping from health records may improve obesity treatment selection. Keep reading to discover future possibilities.

Tezepelumab Reduces Exacerbations and Improves Quality of Life in Severe Asthma

Tezepelumab reduces exacerbations and enhances lung function and quality of life in severe, uncontrolled asthma.

Nurse-Led Tool Forecasts Crisis Risk in Myasthenia Gravis

A newly developed nurse-led nomogram has shown strong potential in predicting the risk of myasthenic crisis in patients with myasthenia gravis and bulbar weakness.

Immunotherapy Plus Chemotherapy Raises Pathologic Complete Response in Early HR-Positive Breast Cancer

Immunotherapy combined with standard neoadjuvant chemotherapy has shown encouraging benefits in hormone receptor positive, HER2 negative early breast cancer, according to new evidence.

The Role of IL-5 Inhibition in CRSwNP and Severe Asthma

At this EAACI 2025 symposium, experts discuss CRSwNP and Severe Asthma, the associated patient burden, and explore the role of IL-5…